# Quant Analyst

- Symbol: CRDO
- Elapsed: 35.5s

---
## CRDO — Credo Technology Group Holding Ltd (Semiconductors, Technology)

**Data caveat up front:** the price feeds disagree materially. `get_company_profile` / `calculate_valuation_ratios` use **$147.51–148.73** (mkt cap ≈$28.0B, 188.2M sh), the daily price history ends **2026-06-18 at $271.83**, and the analyst PTs were published at prices of **$170–219**. I report the multiples exactly as the valuation tool computed them and then give a price-adjusted sensitivity. Any single-price multiple in this name is unreliable.

### 1. Factor Scores

| Factor | Score | Sector Rank* | Signal |
|---|---|---|---|
| Value | 25 / 100 | 3 of 4 | Expensive. P/E 59.3, P/B 13.6, EV/EBITDA 52.1, P/FCF 68.8 (at $148.73). **At $271.83: P/E ≈ 108, P/B ≈ 24.8, EV/EBITDA ≈ 95, P/FCF ≈ 126 → rank 4 of 4.** |
| Momentum (12-1) | 30 / 100 | 3 of 4 | Negative: −4.94% 12-1, −16.44% 6M. But last month +58% (172 → 272), i.e. all the damage is being undone by a violent short-term rip. |
| Quality | 85 / 100 | 1 of 4 | High. ROE 22.9%, GP/assets 0.396, accruals 0.0035 (clean), ROIC 21.3% (vs 5.5% / −6.7% / −5.9% prior three years). Piotroski F 7/9. |
| Low Vol | 5 / 100 | 4 of 4 | Worst in group. Ann. vol 99.7% (252d) / 88.7% (504d), beta 3.38 vs SPY, max drawdown 51.3% (252d) / 53.6% (504d). |
| Earnings Revision | 40 / 100 | 3 of 4 | Mild downgrade: forward consensus −1.07% vs 3 months prior. **Unusable — 2 analysts, period 2031-05-02.** PTs corroborate the weaker drift: Stifel 350→310, Evercore 325→292, Mizuho PT cut to 245. |

*Peer set = CRDO, AVGO, MRVL, ALAB (nearest listed comps; `get_sector_peers` returns only mega-caps). n=4 is a token cross-section — **not** a statistically meaningful sector rank; treat as ordinal context only.

Peer check: AVGO value PE 68.5 / EV-EBITDA 47.1 / FCF 58.9, quality "low" (GP/A 0.253), mom −5.56%. MRVL 74.4 / 44.2 / 142.3, quality "low" (accruals 0.041), mom +33.5%. ALAB 209.2 / 198.5 / 162.6, quality "high" (GP/A 0.421, accruals −0.065), mom +15.7%.

### 2. Price Statistics

| Metric | 252d | 504d |
|---|---|---|
| Alpha (ann., vs SPY) | **−14.62%** | n/a |
| Beta (vs SPY) | 3.395 (profile β 3.25) | 3.33 |
| R² | **0.196** | — |
| Ann. volatility | 100.26% | 88.66% |
| Ann. return | +68.7% | — |
| Sharpe (rf=0) | 0.685 | 1.213 (approx) |
| Sortino | 1.139 | — |
| Max drawdown | 51.31% | 53.59% |

**Significance:** with R² = 0.196 over ~1 year, the alpha estimate is ±~90% annualised — t ≈ −0.16. The −14.6% alpha is **statistically indistinguishable from zero**; equally, the +68.7% return and 0.69 Sharpe have t ≈ 0.7, also insignificant. Only the volatility and beta levels are robustly measured. Beta of 3.4 with 80% of variance idiosyncratic means SPY explains little of CRDO's risk — it is a stock-specific event bet, not a market proxy.

Correlations (252d): ALAB 0.688, AVGO 0.519, MRVL 0.497, SPY 0.441. Tightest link is to ALAB (the other AI-connectivity pure-play) — this is a crowded, single-theme trade.

### 3. Composite Quant Signal: **NEUTRAL** (negative skew)

Equal-weighted factor average ≈ 37/100. Quality is genuinely top-decile (ROIC inflected from −6.7% to +21.3%, clean accruals, F-score 7), but value, momentum, revision and volatility all point the wrong way, and measured alpha is negative. There is no configuration of these five factors that justifies a Buy; the quality/valuation tension is too wide (quality is already fully, arguably over-, paid for). Avoid as a new position; if held, it is a size-down, high-beta satellite rather than a core holding.

### 4. Key Quant Risk Flags

1. **Momentum reversal / blow-off risk (highest).** +58% in 21 trading sessions off a −16% six-month base, with realised vol near 100% and a single-day −11% gap (5/18) inside the run. 12-1 momentum remains negative, so this is a short-term bounce inside a downtrend — the classic entry point for reversal losses.
2. **Valuation fragility to the price discrepancy.** At the tool's $148.73 CRDO screens *cheapest* on EV/EBITDA in the peer set; at $271.83 it screens *most* expensive short of ALAB. A ~1.8x swing in every multiple flips the value factor from 3/4 to 4/4. Do not underwrite this on multiples until price is reconciled.
3. **Factor crowding / theme concentration.** 0.69 correlation to ALAB, and both are AI-datacenter-connectivity pure-plays. Any AI capex de-rate hits CRDO and its "diversified" semi exposure simultaneously.
4. **Estimate quality is thin.** The revision score rests on 2 analysts forecasting FY2031 (−1.07%). FY2028 has 12 analysts (EPS 9.67); FY2031 EPS 13.45 vs FY2026 actual ≈2.51 implies a very long, very steep growth path priced in — duration risk, not a near-term revision signal.
5. **Beta 3.4 / 51% drawdown.** At 100% vol, a 1-sigma monthly move is ±29%. Position sizing, not conviction, is the binding constraint here.
6. **Liquidity is fine** (5–16M shares/day, ~$28–51B cap) — not a constraint; the risk is price, not exit.

**Bottom line:** high-quality operator, no quant support for the current price. Neutral on factors, negative on risk-adjusted expected return.
